Both in Pharmaceuticals
Q32 Bio vs Larimar Therapeutics
Over the past year QTTB returned +240.9% and LRMR returned −34.5%; their daily moves had a correlation of 0.03.
QTTB +240.9% LRMR −34.5%Growth of $1, one year, split-adjusted
| Metric | QTTB | LRMR |
|---|---|---|
| Price | $8.76 | $2.54 |
| Market cap | $260.8M | $263.9M |
| Today | +0.57% | +7.17% |
| 1 month | +4.7% | −11.2% |
| 6 months | +70.4% | −36.7% |
| Year to date | +163.9% | −33.3% |
| 1 year | +211.7% | −34.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 7.7× | — |
| Price / sales | 4.9× | — |
| Net cash | $106.3M | $156.3M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 79.0% |
| Short % of float | 32.6% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).